Condition
Primary Open Angle Glaucoma (POAG) clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Primary Open Angle Glaucoma (POAG) clinical trials that are recruiting, at sites in 8 countries (most in United States (4), South Korea (1), India (1)). 1 was first registered in the last 30 days. By phase: Phase 3 (2), Phase 1/2 (2), Phase 4 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 1New in 30 days
- 8Countries
Newest Primary Open Angle Glaucoma (POAG) clinical trials
All recruiting trials (10)
-
Pregabalin eye drops vs timolol eye drops for open-angle glaucoma or ocular hypertension
A doctor-led study tests whether pregabalin eye drops (TB0001) work as well as timolol eye drops to lower eye pressure in adults with glaucoma or high eye pressure.
-
REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
This study tests REGN22530 in adults with POAG or ocular hypertension to see if it can lower eye pressure and what kind of side effects it may have.
-
Is a preservative-free Bimatoprost 0.01% as effective and safe as Lumigan in POAG or ocular hypertension?
This study tests whether a preservative-free Bimatoprost 0.01% (YSBP) works as well as Lumigan 0.01% for people with POAG or ocular hypertension.
-
Analyzing eye fluid and tissues to find glaucoma-related markers in people with cataracts.
This study will test whether protein and elemental patterns in eye fluid and tissues taken during cataract surgery differ between people with primary open-angle glaucoma and those without glaucoma.
-
Eye imaging after combined deep sclerectomy and trabeculotomy for open-angle glaucoma
This study uses ultrasound biomicroscopy to see if specific postoperative eye anatomy after combined deep sclerectomy and trabeculotomy links to better pressure control in people with primary open-angle glaucoma.
-
HUC3-637 for primary open-angle glaucoma and ocular hypertension
This study tests whether HUC3-637 is safe and can lower eye pressure in adults with primary open-angle glaucoma or ocular hypertension.
-
BrudyGlauco (DHA and citicoline) for people with glaucoma
This trial will test whether taking BrudyGlauco (DHA plus citicoline) for 12 months helps preserve visual field in adults aged 50–75 with glaucoma.
-
Direct Selective Laser Trabeculoplasty to lower eye pressure in non‑Caucasian adults with open-angle glaucoma
This trial will try Direct Selective Laser Trabeculoplasty (DSLT) to lower eye pressure in adult non‑Caucasian patients with mild to moderate primary open‑angle glaucoma.
-
GVB-2001 gene therapy injected into the front of the eye for primary open-angle glaucoma
This will try a gene therapy (GVB-2001) given by intracameral injection to lower high eye pressure in adults with primary open-angle glaucoma.
-
Investigating oral semaglutide for treating open-angle glaucoma
This study is testing if a daily pill called semaglutide can help improve vision in people with open-angle glaucoma.
Related topics
Quick answers
How many Primary Open Angle Glaucoma (POAG) clinical trials are recruiting right now?
10, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (4 trials), South Korea (1 trial), India (1 trial), Spain (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1/2: 2, Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.